1H-NMR spectroscopy of body fluids: Inborn errors of purine and pyrimidine metabolism

Clinical Chemistry

Volumn 45, Issue 4, 1999, Pages 539-548

  Wevers, Ron A ^a   Engelke, Udo F H ^a   Moolenaar, Sytske H ^a   Bräutigam, Christa ^b   De Jong, Jan G N ^a   Duran, Ries ^c   De Abreu, Ronney A ^a   Van Gennip, Albert H ^d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2,8 DIHYDROXYADENINE; ADENINE PHOSPHORIBOSYLTRANSFERASE; ADENOSINE DEAMINASE; ADENYLOSUCCINATE LYASE; DIHYDROPYRIMIDINASE; DIHYDROPYRIMIDINE DEHYDROGENASE; PURINE NUCLEOSIDE PHOSPHORYLASE; THYMINE; URACIL; URIC ACID; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

ARTICLE; BODY FLUID; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; ENZYME DEFECT; ENZYME DEFICIENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INBORN ERROR OF METABOLISM; INTERMETHOD COMPARISON; PROTON NUCLEAR MAGNETIC RESONANCE; PURINE METABOLISM; PYRIMIDINE METABOLISM; XANTHINURIA; BLOOD; CEREBROSPINAL FLUID; ENZYMOLOGY; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; URINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; METABOLISM, INBORN ERRORS; PURINES; PYRIMIDINES;

EID: 0032587350     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.4.539     Document Type: Article

References (23)

1. 1. Nicholson JK, Wilson ID. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog Nucl Magn Reson Spectrosc 1989;21:449-501.
2. 2. Bell JD, Brown JCC, Sadler PJ. NMR studies of body fluids. Nucl Magn Reson Biomed 1989;2:246-55.
3. 1H-NMR spectroscopy of blood plasma for metabolic studies. Clin Chem 1995;41:1054-6.
4. 1H-FT-NMR spectrometry. Eur J Pediatr 1986;145:260-6.
5. 1H-NMR of cerebrospinal fluid. Clin Chem 1995;41:744-51.
6. 6. Abeling NGGM, van Gennip AH, Bakker HD, Heerschap A, Engelke U, Wevers RA. Diagnosis of a new case of trimethylaminuria using direct proton NMR spectroscopy of urine. J Inherit Metab Dis 1995;18:182-4.
7. 1H-NMR spectroscopy of blood plasma for metabolic studies. Clin Chem 1994;40:1245-50.
8. 8. Iles RA, Chalmers RA. Nuclear magnetic resonance spectroscopy in the study of inborn errors of metabolism. Clin Sci 1988;74: 1-10.
9. 9. Putman CWMM, Rotteveel JJ, Wevers RA, van Gennip AH, Bakkeren JAJM, de Abreu RA. Dihydropyrimidinase deficiency: a progressive neurological disorder? Neuropediatrics 1997;28:106-10.
10. 10. Assmann B, Hoffmann GF, Wagner L, Bräutigam C, Seyberth HW, Duran M, et al. Dihydropyrimidinase deficiency and congenital microvillous atrophy: coincidence or genetic relation? J Inherit Metab Dis 1997;20:681-8.
11. 31P nuclear magnetic resonance. Experientia 1986;42:69-72.
12. 2H-NMR spectroscopy of body fluids in patients with inborn errors of purine and pyrimidine metabolism. J Inherit Metab Dis 1997;20:345-50.
13. 13. van Gennip AH, de Abreu RA, Van Lenthe H, Bakkeren J, Rotteveel J, Vreken P, van Kuilenburg ABP. Dihydropyrimidinase deficiency: confirmation of the enzyme defect in dihydropyrimidinuria. J Inherit Metab Dis 1997;20:339-42.
14. 14. van Gennip AH, de Abreu RA, Vreken P, van Kuilenburg ABP. Clinical and biochemical aspects of dihydropyrimidinase deficiency. Adv Exp Biol 1998;431:125-8.
15. 15. Rijksen G, Kuis W, Wadman SK, Spaapen LJM, Duran M, Voorbrood BS, et al. A new case of purine nucleoside phosphorylase deficiency: enzymological, clinical and immunological characteristics. Pediatr Res 1987;21:137-41.
16. 16. Stoop JW, Zegers BJM, Hendrickx GFM, Siegenbeek van Heukelom LH, Staal GEJ, de Bree PK, et al. Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. New Engl J Med 1977;296:651-5.
17. 17. van Gennip AH, Mandel H, Stroomer LEM, van Cruchten AG. Effect of allopurinol on the xanthinuria in a patient with molybdenum cofactor deficiency. Adv Exp Med Biol 1995;370:375-8.
18. 18. van Gennip AH, Van Lenthe H, Abeling NGGM, Scholten EG, van Kuilenburg ABP. Inhibition of β-ureidopropionase by propionate may contribute to the neurological complications in patients with propionic acidaemia. J Inherit Metab Dis 1997;20:379-82.
19. 19. van Gennip AH, Busch S, Elzinga L, Stroomer AEM, van Cruchten A, Scholten EG, Abeling NGGM. Application of simple chromatographic methods for the diagnosis of defects in pyrimidine degradation. Clin Chem 1993;39:380-5.
20. 20. van Gennip AH, Busch S, Scholten EG, Stroomer AEM, Abeling NG. Simple method for the quantitative analysis of dihydropyrimidines and N-carbamyl-β-amino acids in urine. Adv Exp Med Biol 1991; 3098:15-9.
21. 21. Cohen A, Staal GE, Ammann AJ, Martin DW. Orotic aciduria in two unrelated patients with inherited deficiencies of purine nucleoside phosphorylase. J Clin Investig 1977;60:491-4.
22. 22. van Gennip AH, Grift J, de Bree PK, Zegers BJM, Stoop JW, Wadman SK. Urinary excretion of orotic acid, orotidine and other pyrimidines in a patient with purine nucleotide phosphorylase deficiency. Clin Chim Acta 1979;93:419-28.
23. 23. Simmonds HA, Potter CF, Sahota A, Cameron JS, Webster DR, Becroft DM. Absence of orotic aciduria in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. Clin Exp Immunol 1978;34:42-5.